Insider Selling: Oscar Health (NYSE:OSCR) Insider Sells $406,620.70 in Stock

Oscar Health, Inc. (NYSE:OSCR) insider Mario Schlosser sold 23,038 shares of Oscar Health stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of $17.65, for a total value of $406,620.70. Following the completion of the transaction, the insider owned 350,180 shares of the company’s stock, valued at $6,180,677. The trade was a 6.17% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Mario Schlosser also recently made the following trade(s):

• On Tuesday, January 6th, Mario Schlosser sold 76,962 shares of Oscar Health stock. The stock was sold at an average price of $17.01, for a total transaction of $1,309,123.62.
• On Wednesday, December 24th, Mario Schlosser sold 38,835 shares of Oscar Health stock. The shares were sold at an average price of $15.00, for a total transaction of $582,525.00.
• On Tuesday, December 2nd, Mario Schlosser sold 23,965 shares of Oscar Health stock. The stock was sold at an average price of $16.59, for a total transaction of $397,579.35.
• On Tuesday, November 11th, Mario Schlosser sold 286,182 shares of Oscar Health stock. The stock was sold at an average price of $15.27, for a total transaction of $4,369,999.14.

Oscar Health Trading Down 3.8%

Shares of NYSE:OSCR opened at $16.71 on Thursday. Oscar Health, Inc. has a 52 week low of $11.20 and a 52 week high of $23.80. The company’s 50 day moving average is $15.80 and its two-hundred day moving average is $16.88. The company has a market cap of $4.42 billion, a PE ratio of -14.92 and a beta of 1.90. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.02. The firm had revenue of $2.93 billion during the quarter, compared to the consensus estimate of $3.09 billion. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The company’s revenue was up 23.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.22) earnings per share. Equities analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Oscar Health

A number of hedge funds have recently modified their holdings of the business. SG Americas Securities LLC increased its holdings in shares of Oscar Health by 886.8% in the 4th quarter. SG Americas Securities LLC now owns 921,288 shares of the company’s stock valued at $13,239,000 after acquiring an additional 827,929 shares during the period. Assenagon Asset Management S.A. purchased a new position in Oscar Health during the 4th quarter worth $9,208,000. IFP Advisors Inc raised its holdings in shares of Oscar Health by 2,762.6% in the third quarter. IFP Advisors Inc now owns 6,498 shares of the company’s stock valued at $123,000 after buying an additional 6,271 shares during the last quarter. Cantor Fitzgerald L. P. raised its holdings in shares of Oscar Health by 2.2% in the third quarter. Cantor Fitzgerald L. P. now owns 125,144 shares of the company’s stock valued at $2,369,000 after buying an additional 2,637 shares during the last quarter. Finally, CIBC Bancorp USA Inc. acquired a new stake in shares of Oscar Health during the third quarter worth about $392,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Zacks Research raised Oscar Health from a “strong sell” rating to a “hold” rating in a report on Monday, October 13th. Wells Fargo & Company reduced their price objective on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating for the company in a research report on Thursday, November 13th. Wall Street Zen cut shares of Oscar Health from a “hold” rating to a “sell” rating in a report on Saturday, December 6th. UBS Group raised shares of Oscar Health from a “sell” rating to a “neutral” rating and increased their target price for the company from $12.00 to $17.00 in a research report on Friday, January 9th. Finally, Barclays set a $18.00 price target on shares of Oscar Health and gave the company an “equal weight” rating in a research report on Monday, January 5th. One analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Reduce” and a consensus target price of $17.00.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.